95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.20%
Revenue growth similar to OR's 9.92%. Walter Schloss would see if both companies share industry tailwinds.
-7.24%
Negative gross profit growth while OR is at 10.18%. Joel Greenblatt would examine cost competitiveness or demand decline.
46.83%
EBIT growth above 1.5x OR's 15.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
46.83%
Operating income growth above 1.5x OR's 7.56%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
22.02%
Net income growth at 75-90% of OR's 26.20%. Bill Ackman would press for improvements to catch or surpass competitor performance.
16.67%
EPS growth at 75-90% of OR's 21.43%. Bill Ackman would push for improved profitability or share repurchases to catch up.
No Data
No Data available this quarter, please select a different quarter.
10.24%
Share count expansion well above OR's 0.41%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
10.44%
Diluted share count expanding well above OR's 0.35%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
14.42%
OCF growth 1.25-1.5x OR's 11.49%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
27.48%
Positive FCF growth while OR is negative. John Neff would see a strong competitive edge in net cash generation.
75.71%
10Y revenue/share CAGR under 50% of OR's 191.83%. Michael Burry would suspect a lasting competitive disadvantage.
No Data
No Data available this quarter, please select a different quarter.
-36.46%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
936.18%
5Y OCF/share CAGR above 1.5x OR's 192.29%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-41.26%
Negative 3Y OCF/share CAGR while OR stands at 22738.42%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
657.46%
5Y net income/share CAGR above 1.5x OR's 117.59%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-46.67%
Negative 3Y CAGR while OR is 86.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
2332.51%
Positive 5Y equity/share CAGR while OR is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
60.11%
Positive short-term equity growth while OR is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
220.52%
AR growth well above OR's 8.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
13.22%
Asset growth above 1.5x OR's 3.85%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.70%
75-90% of OR's 5.86%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-4.54%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-1.31%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.